10x Genomics Inc (NAS:TXG)
$ 24.83 -0.18 (-0.72%) Market Cap: 2.97 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 76/100

10X Genomics Inc at JPMorgan Healthcare Conference Transcript

Jan 08, 2024 / 05:00PM GMT
Release Date Price: $53.41 (+3.43%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Hi, everyone. This is Rachel Vatnsdal, from the Life Science Tools and Diagnostics team with JPMorgan. Thank you so much for joining me today. I've got 10x Genomics on stage. I'm first going to introduce Serge, CEO of 10x. He is going to start off with a presentation around 20 minutes, give or take, and then I'll shift to Q&A. If anyone in the room has questions, please feel free to either submit them via the app or you can pin me directly.

Serge Saxonov
10x Genomics, Inc. - Co-Founder, CEO & Director

Thank you. Really great to be back here. So before we begin, I want to point out our safe harbor statement on Slide 2 and invite you to visit our website for additional disclosures regarding forward-looking statements made today.

So 2023, we had another strong year, finishing with $619 million in revenue, representing 20% growth from a year before. We had big increases in customer publications in intellectual property and in our installed base of instruments. In

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot